Sumatriptan (Lannett Company, Inc.)


Welcome to the PulseAid listing for the Sumatriptan drug offered from Lannett Company, Inc.. This Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Lannett Company, Inc.
NON-PROPRIETARY NAME: Sumatriptan
SUBSTANCE NAME: SUMATRIPTAN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
ROUTE: NASAL
DOSAGE FORM: SPRAY
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2016-02-19
END MARKETING DATE: 0000-00-00


Sumatriptan HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSumatriptan from Lannett Company, Inc.
LABELER NAME: Lannett Company, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 5(mg/.1mL)
START MARKETING DATE: 2016-02-19
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0527-1818_04733454-0f9f-4bd7-912f-fde83f0b8051
PRODUCT NDC: 0527-1818
APPLICATION NUMBER: ANDA204841

Other SUMATRIPTAN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
GlaxoSmithKline LLCIMITREX
Lannett Company, Inc.Sumatriptan
Physicians Total Care, Inc.SUMATRIPTAN
Sandoz IncSUMATRIPTAN